In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion

dc.contributor.author	Thangavelu PU
dc.contributor.author	Krenács, Tibor
dc.contributor.author	Dray E
dc.contributor.author	Duijf PHG
dc.date.accessioned	2018-06-11T08:06:06Z
dc.date.available	2018-06-11T08:06:06Z
dc.date.issued	2016
dc.identifier.citation	pagination=120, pages: 13; journalVolume=8; journalTitle=CLINICAL EPIGENETICS;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/5558
dc.identifier.uri	doi:10.1186/s13148-016-0290-6
dc.relation.ispartof	urn:issn:1868-7075
dc.title	In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion
dc.type	Journal Article
dc.date.updated	2018-06-07T08:43:10Z
dc.language.rfc3066	en
dc.identifier.mtmt	3322473
dc.identifier.wos	000390487300001
dc.identifier.pubmed	27891193
dc.contributor.department	SE/AOK/I/I. Sz. Patológiai és Kísérleti Rákkutató Intézet
dc.contributor.institution	Semmelweis Egyetem